memantine

(redirected from memantine hydrochloride)
Also found in: Medical.
Related to memantine hydrochloride: donepezil hydrochloride

me·man·tine

 (mə-măn′tēn)
n.
A drug, C20H24N5O4, used in its hydrochloride form to treat symptoms of Alzheimer's disease by inhibiting NMDA receptors.

[me(thyl) + (ada)mant(ane), molecule with a diamond-like structure (from Greek adamās, adamant-, diamond; see adamant) + -ine.]
Translations

memantine

n memantina
References in periodicals archive ?
Amneal Pharmaceuticals has launched memantine hydrochloride extended-release capsules, the company's AB-rated equivalent for Namenda, in 7 mg, 14 mg, 21 mg and 28 mg strengths.
M2 EQUITYBITES-July 12, 2017-Zydus Cadila granted final FDA approval to commercialise Memantine Hydrochloride
M2 PHARMA-July 12, 2017-Zydus Cadila granted final FDA approval to commercialise Memantine Hydrochloride
The FDA approval of an abbreviated new drug application for memantine hydrochloride tablets, the equivalent to branded Namenda, indicated for moderate to severe dementia of the Alzheimer's type brings the number of quality generic prescription products in Upsher-Smith's portfolio to more than 35, with more than 300 SKUs.
Tenders are invited for Memantine Hydrochloride 10Mg Tab
The second type of drug, memantine hydrochloride (Namenda [R]), helps regulate the neurotransmitter glutamate, which is overproduced in AD.
NAMENDA XR is contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation.
His medications were aspirin 81 mg qd, clopidogrel 75 mg qod, escitalopram oxalate 10 mg qd, quetiapine fumarate 25 mg qd, and memantine hydrochloride 10 mg qd.
6] Based on these findings, in 2003 memantine hydrochloride was approved by the United States Food and Drug Administration for the treatment of moderate to severe AD.
5 and Mini-Mental State Examination scores between 10 and 22, found that patients on memantine hydrochloride (Namenda, 10 mg b.
said Tuesday they will jointly develop in Japan a new drug to treat Alzheimer's disease called memantine hydrochloride.
M2 EQUITYBITES-November 15, 2016-Lannett awarded US FDA approval for Memantine Hydrochloride Tablets USP, 5 mg And 10 mg